$CE

Duffie Ashley B purchased $27K of CE

Duffie Ashley B (SVP & GC) purchased 600 shares of Celanese Corp (CE) at $45.60 on 2026-08-11.

Original reporting
SEC EDGAR · Duffie Ashley B
Published Aug 13, 2026, 8:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 13, 2026, 8:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CE
Bullish
medium confidence
Mentioned
$CE
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CEBullishLow
01

Why it matters

The newest fact is the open-market purchase of 600 shares at $45.60, totaling $27,360, with holdings after the trade of 31,925 shares.

02

Market read

Traders may note the insider buy as a minor sentiment input, but there is no accompanying operational or financial update in the text.

03

What to watch

The article does not state whether the purchase was part of a broader pattern, nor does it provide context like prior buys/sells or option exercises.

Relevance 4/10Novelty 5/10Timing: Form 4 filed 2026-08-13, covering an 2026-08-11 purchase.

Background

The article is a SEC Form 4 insider transaction disclosure for Celanese Corp, reported by SVP and General Counsel Duffie Ashley B.

Company-level read

Ticker impact

$CEBullishMedium confidence
Context

Celanese insider Duffie Ashley B bought 600 shares at $45.60 on 2026-08-11, disclosed via Form 4 filed 2026-08-13.

Expected impact

Limited near-term impact; any effect is likely short-lived unless followed by additional disclosures or company-specific news.

Evidence & confidence

The filing is a primary-source Form 4, but the transaction size ($27.36k) is modest and there is no 10b5-1 plan or other accompanying corporate event in the text.

Market effects

No sector-level implications are provided; this is company-specific insider activity only.

None indicated; the disclosure is not tied to regional demand or policy.

None indicated; no international operations or global catalyst is mentioned.

Counterpoint

Insider buys can be driven by diversification, liquidity needs, or pre-planned behavior, so the signal may be weaker than it appears.

Key entities

  • Celanese Corp

    US-listed company (CE) whose insider transaction is disclosed.

  • Duffie Ashley B

    SVP and General Counsel who reported the purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CEMed

KeyBanc initiates Celanese stock coverage with overweight rating

KeyBanc initiated coverage on Celanese (NYSE: CE) with an overweight rating and a $57 price target, citing attractive valuation and strong free cash flow yield. The firm estimates the company has sufficient liquidity to repay debt through 2028. Celanese's Q2 2026 earnings beat estimates but revenue missed slightly, with a cautious outlook due to restructuring and leverage concerns.

$CEMed

Mitsui to Integrate Nutrinova's Upstream Materials Production and Make Nutrinova a Consolidated Subsidiary

Mitsui & Co. will integrate upstream operations at VP4, a German producer of key intermediates for Nutrinova's food ingredients. Mitsui will acquire an additional 19% stake in Nutrinova from Celanese, increasing its holding to 89% and making Nutrinova a consolidated subsidiary. This move aims to secure supply, improve cost competitiveness, and align with Mitsui's growth strategy in the Food Science business.

$CEMed

Celanese (CE) Beat Estimates, So Why Is Guidance Getting Trickier?

Celanese (NYSE:CE) beat May-set expectations in Q2 but signaled a tougher Q3 on an earnings call Aug. 4. Management attributed the swing to timing and flexing of its production network, accelerated plant shutdowns, weaker equity earnings from the Ibn Sina JV, and regional margin/volume pressures. CE kept 2026 free cash flow guidance at $700M to $800M and reiterated $1B divestitures by end-2027.

$CELow

Celanese Corp (CE): Results of Operations and Financial Condition

Celanese Corp (CE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Celanese Corporation Reports Second Quarter Earnings Dallas, August 4, 2026: Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today reported second quarter 2026 U.S. GAAP diluted earnings per share of $1.15 and adjusted earnings per